![]() |
![]() |
press room |
|
Press KitRepromedix Fact Sheet Press ReleasesRepromedix Launches Biological Clock Test For Women Repromedix Appoints Dr. Michael J. Burns Chief Executive Officer Repromedix Licenses Technology From Whitehead Institute to Develop Advanced Male Infertility Test For Genetic Abnormalities Repromedix Adds Two Tests for Reproductive Failure to Its Advanced Diagnostic Test Panels Miscarriages May Be a Symptom of Greater Health Risk Repromedix Appoints Paul Kowalski as Sales VP Repromedix Receives $2.2 Million in Series A Venture Funding Repromedix Expands Cystic Fibrosis Test Offerings Noted Male Infertility Specialist David Brown, PhD Joins Repromedix R&D Staff Sperm DNA Fragmentation Assay (SDFA™) from Repromedix Proven Equivalent to Evenson’s SCSA™ Repromedix Appoints Senior Nursing Professional Becky Waldman as Clinical Education Manager Repromedix Launches Advanced Diagnostic Tests for Male Infertility ArticlesIs Your Job Making You Infertile? New Test Detects Sperm Damage from Workplace Toxins Noted Infertility Specialists Participate In Repromedix Roundtable On Advanced Infertility Diagnostics Advanced Tests Bring Hope To Couples Struggling With Unexplained Infertility The Man, The Myth and the Sperm: |
|||